We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$106B
AUM Growth
-$22.4B
Cap. Flow
+$44.2B
Cap. Flow %
41.6%
Top 10 Hldgs %
42.41%
Holding
4,108
New
765
Increased
1,315
Reduced
1,298
Closed
285

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.85B
2
EQIX icon
Equinix
EQIX
+$2.31B
3
TSLA icon
Tesla
TSLA
+$2.3B
4
SNDK
SANDISK CORP
SNDK
+$1.87B
5
TRLA
TRULIA INC (DEL)
TRLA
+$1.64B

Sector Composition

Rank Sector Weight
1 Technology 4.77%
2 Financials 3.07%
3 Industrials 1.75%
4 Healthcare 1.67%
5 Materials 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVAX
2951
DELISTED
Dynavax Technologies
DVAX
$2.31K ﹤0.01%
+144
New +$2.17K
COB
2952
DELISTED
CommunityOne Bancorp
COB
$2.31K ﹤0.01%
238
+185
+349% +$1.87K
STX icon
2953
PUT
Seagate
STX
$186B
$2.3K ﹤0.01%
+50
New +$2.69K
CAS
2954
DELISTED
A M Castle & Co
CAS
$2.3K ﹤0.01%
208
+170
+447% +$2.14K
NEON icon
2955
Neonode
NEON
$16.4M
$2.29K ﹤0.01%
+73
New +$3.17K
INFN
2956
DELISTED
Infinera Corporation Common Stock
INFN
$2.29K ﹤0.01%
249
+54
+28% +$480
CBNJ
2957
DELISTED
CAPE BANCORP, INC COM
CBNJ
$2.29K ﹤0.01%
213
ZAZA
2958
DELISTED
ZAZA ENERGY CORP COM NEW
ZAZA
$2.28K ﹤0.01%
259
+9
+4% +$58
PRTK
2959
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.27K ﹤0.01%
95
BPFH
2960
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$2.27K ﹤0.01%
+169
New +$2.17K
KAI icon
2961
Kadant
KAI
$4B
$2.27K ﹤0.01%
+59
New +$2.18K
ROIC
2962
DELISTED
Retail Opportunity Investments Corp.
ROIC
$2.27K ﹤0.01%
144
-3,486
-96% -$54.5K
TBI
2963
Trueblue
TBI
$310M
$2.26K ﹤0.01%
+82
New +$2.25K
TLOG
2964
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$2.26K ﹤0.01%
+383
New +$2.17K
REGN icon
2965
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
$2.25K ﹤0.01%
450
RH icon
2966
PUT
RH
RH
$3.46B
$2.25K ﹤0.01%
+150
New +$10.5K
COHR
2967
DELISTED
Coherent Inc
COHR
$2.25K ﹤0.01%
+34
New +$2.1K
SGNT
2968
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.25K ﹤0.01%
+87
New +$1.93K
DLB icon
2969
Dolby
DLB
$5.75B
$2.25K ﹤0.01%
52
DXLG icon
2970
Destination XL Group
DXLG
$32.2M
$2.24K ﹤0.01%
+407
New +$2.16K
NGD
2971
DELISTED
New Gold Inc
NGD
$2.24K ﹤0.01%
+999
New +$5.38K
CIR
2972
DELISTED
CIRCOR International, Inc
CIR
$2.24K ﹤0.01%
+29
New +$2.24K
HBIO icon
2973
Harvard Bioscience
HBIO
$27.6M
$2.23K ﹤0.01%
49
+44
+880% +$1.85K
EBF icon
2974
Ennis
EBF
$560M
$2.23K ﹤0.01%
+146
New +$2.25K
SUNE
2975
SUNation Energy
SUNE
$10.6M
0

Similar funds

BNP Paribas Financial Markets's Q2 2014 Portfolio in Review

As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.

  • BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
  • BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
  • BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
  • BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
  • BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
  • BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
  • BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.